PG
POSTE GEORGE
Director
OFFICERM
Insider track record
ExecutiveAcross 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by POSTE GEORGE, Director. Insider active across 3 companies, notably Exelixis, INC.. In total, 20 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €8.1m. History available since 14 May 2021. The latest transaction was filed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations20 total
1,600 shares@ US$15.62100.0% of flowCommon StockSEC:0001180770-26-000003:0
8,367 shares0Common StockSEC:0000939767-26-000075:0
60,000 shares@ US$45.710.018% mcap36.7% of flowCommon StockSEC:0000939767-26-000061
60,000 shares@ US$45.710.020% mcap36.7% of flowCommon StockSEC:0000939767-26-000061:0
9,812 shares0Common StockSEC:0000939767-25-000091:0
20,634 shares@ US$19.773.9% of flowCommon StockSEC:0000939767-25-000083:0
15,874 shares@ US$20.503.4% of flowCommon StockSEC:0000939767-25-000026:0
30,000 shares@ US$34.0010.1% of flowCommon StockSEC:0000939767-24-000155:0
33,725 shares@ US$26.899.0% of flowCommon StockSEC:0000939767-24-000127:0
18,838 shares0Common StockSEC:0000939767-24-000101:0
11,686 shares@ US$19.572.3% of flowCommon StockSEC:0000939767-24-000076:0
20,718 shares0Common StockSEC:0000939767-23-000059:0
40,000 shares@ US$6.302.6% of flowCommon StockSEC:0000939767-22-000116:0
19,575 shares0Common StockSEC:0000939767-22-000080:0
16,424 shares0Common StockSEC:0000939767-21-000059:0
16,424 shares0Common StockSEC:0000939767-21-000059
40,802 shares@ US$24.9713.3% of flowCommon StockSEC:0000939767-21-000052
40,802 shares@ US$24.970.0073% mcap13.3% of flowCommon StockSEC:0000939767-21-000052:0
205 sharesCommon StockSEC:0001110783-16-000359:0
13,830 sharesCommon StockSEC:0000939767-16-000128:0
About POSTE GEORGE
George Poste is a Director at Exelixis, Inc. He contributes to the company's governance by participating in board meetings and providing his expertise in the biopharmaceutical sector. George plays an important role in making strategic decisions for Exelixis.